Literature DB >> 6336343

Diarrhea and metformin in a diabetic clinic.

P Dandona1, V Fonseca, A Mier, A G Beckett.   

Abstract

In a questionnaire-based survey of 285 randomly selected diabetic patients, diarrhea was found to occur in 8%; this was found to be similar to that in 150 nondiabetic control patients attending other medical clinics (8%). When the diabetic patients were divided into separate therapeutic groups, metformin-treated (with or without sulfonylureas) patients had a markedly greater prevalence of diarrhea (20%) than those not on this drug (6%). A majority of patients with metformin-associated diarrhea had soiling of clothes as a problem, while at least two complained of frank loss of control over their anal sphincter. These patients did not have autonomic neuropathy, and in all who stopped this drug, diarrhea settled within 2-5 days. Only 6% of insulin-dependent diabetic individuals (IDD) had diarrhea, one of whom had explosive nocturnal stools with incontinence and features diagnostic of autonomic neuropathy. Metformin is by far the commonest cause of diarrhea and incontinence in our diabetic clinic, where it is used routinely. In contrast, diarrhea due to autonomic neuropathy is rare.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336343     DOI: 10.2337/diacare.6.5.472

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

Review 1.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 2.  Management of colorectal cancer and diabetes.

Authors:  Caroline Yao; Guy F Nash; Tamas Hickish
Journal:  J R Soc Med       Date:  2013-12-13       Impact factor: 5.344

Review 3.  A rational approach to drug therapy of type 2 diabetes mellitus.

Authors:  J M Chehade; A D Mooradian
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 5.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

6.  Prediction and validation of enzyme and transporter off-targets for metformin.

Authors:  Sook Wah Yee; Lawrence Lin; Matthew Merski; Michael J Keiser; Aakash Gupta; Youcai Zhang; Huan-Chieh Chien; Brian K Shoichet; Kathleen M Giacomini
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-03       Impact factor: 2.745

Review 7.  Comparative tolerability profiles of oral antidiabetic agents.

Authors:  A J Krentz; R E Ferner; C J Bailey
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

8.  Update on Safety Issues Related to Antihyperglycemic Therapy.

Authors:  Gandahari Rosa A Carpio; Vivian A Fonseca
Journal:  Diabetes Spectr       Date:  2014-05

Review 9.  Drug therapy of non-insulin-dependent diabetes mellitus in the elderly.

Authors:  A D Mooradian
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 10.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.